Pioneering bone marrow transplantation – Led by Nobel Prize winner Dr. E. Donnall Thomas, Fred Hutch researchers have transformed bone marrow transplantation into standard treatment for leukemia, lymphoma and other blood cancers. The procedure is one of cancer treatment's biggest success stories and has saved hundreds of thousands of patients' lives. Learn more >
Developing therapies that zero in on cancer cells – Our scientists are currently researching substances that find cancer cells and carry cancer-killing substances to them without harming healthy cells. One study, led by Dr. Ajay Gopal, looks to administer the antibody prior to stem cell transplant in treating patients with relapsed or refractory Hodgkin lymphoma or non-Hodgkin lymphoma. Learn more >
Investigating new drug therapies – Dr. Leona Holmberg is leading a clinical trial examining the drug brentuximab vedotin as an effective therapy for treating post-stem cell transplantation patients who are at high risk of residual Hodgkin lymphoma. Learn more >
Evaluating combination treatments – Dr. Oliver Press is leading a clinical trial to study fludeoxyglucose F 18-PET/CT imaging to see how well it works in assessing response to combination chemotherapy and allow doctors to plan better additional further treatment in treating patients with late stage Hodgkin lymphoma.
Learn more >
Reducing cancer worldwide - Nearly a quarter of the world’s cancers are caused by infectious diseases that are preventable or treatable, which include lymphoma from Epstein-Barr virus, sarcomas associated with HIV, cervical cancer from human papillomavirus and liver cancer from hepatitis B and C. To reduce the burden of cancer worldwide, Fred Hutch has united with the Uganda Cancer Center to open a new state-of-the-art research, training and clinical care facility—UCI-Fred Hutch Cancer Centre— a major milestone.
Learn more >